Edinburg, Scotland, United Kingdom
Lentivirus is challenging to manufacture. Unwanted transgene expression and viral genome instability are two common and critical issues. Lentitek can help you solve these challenges through a combination of expert design services and the incorporation of our unique manufacturing technology, which effectively eliminates unwanted transgene expression by stabilising the vector genome during the manufacturing process. Our approach enables you to optimise vector performance, enhance quality and safety, and minimise potentially hazardous off-target effects.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Lentitek on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
